Skip to content

Advertisement

  • Research article
  • Open Access

Vitamin D deficiency in patients with cluster headache: a preliminary study

  • 1,
  • 2,
  • 3,
  • 4 and
  • 5Email author
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201819:54

https://doi.org/10.1186/s10194-018-0886-7

  • Received: 13 May 2018
  • Accepted: 9 July 2018
  • Published:

Abstract

Background

Cluster headache is famous for attacks with seasonal and diurnal periodicity. This diurnal and seasonal variation might be related to sunlight and vitamin D metabolism. We investigated the serum vitamin D levels in patients with cluster headache.

Methods

We enrolled patients with cluster headache and age- and sex-matched migraineurs and normal controls. From October 2016 to March 2018, non-fasting serum 25(OH)D concentrations were measured using a chemiluminescent immunoassay. Vitamin D deficiency was defined as a concentration < 20 ng/mL.

Results

The study enrolled 28 patients with cluster headache, 36 migraineurs, and 36 normal controls. In the patients with cluster headache, the serum 25(OH)D concentration averaged 14.0 ± 3.9 ng/mL and 92.8% had vitamin D deficiency. There was no significant difference among the patients with cluster headache, migraineurs, and controls. In the patients with cluster headache, there was no difference in the serum 25(OH)D concentrations between men and women, cluster and remission periods, first and recurrent attack, presence and absence of daily or seasonal periodicity, and 3-month recurrence. In the 14 patients with seasonal periodicity, patients with periodicity of winter to spring had a trend of lower serum 25(OH)D concentrations than those with periodicity of summer to autumn (12.30 ± 1.58 vs. 16.96 ± 4.69 ng/mL, p = 0.097).

Conclusions

Vitamin D deficiency is common in patients with cluster headache, but the role of vitamin D deficiency is uncertain, except for its seasonal influence.

Keywords

  • Vitamin D
  • Deficiency
  • Cluster headache
  • Migraine

Background

Vitamin D is produced in the skin after oral absorption and exposure to sunlight. It is transformed by the liver and kidneys and plays a crucial role in promoting bone and muscle health. Vitamin D deficiency is a global health issue and is associated with inflammation, autonomic function, autoimmune disorders, chronic pain, cancer, and vascular and neurological disorders, in addition to its skeletal roles [16].

The estimated prevalence of vitamin D deficiency in North America, Europe and Australia is as high as 20–50% [713]. Vitamin D deficiency is more common in Korea (37° N) where the prevalence in male and female adult workers was 69.5 and 83.1%, respectively [14]. The determinants of vitamin D levels are the amount of skin exposure, followed by location, season, personal ultraviolet radiation exposure, vitamin D supplementation, body mass index, and physical activity [15].

A high prevalence of all kinds of headache has been associated with high latitude, suggesting a relationship with vitamin D [16]. However, the inter-relationships of vitamin D deficiency and headache are still uncertain. The studies of vitamin D in primary headache disorders have focused mainly on migraine, although there is no systematic evidence of an association between vitamin D deficiency and migraine [1719]. There are case reports of migraine patients who improved with vitamin D supplementation [20, 21]. Simvastatin plus vitamin D has been reported to be effective for preventing headache in adults with episodic migraine in randomized clinical trials [22]. Dysfunction of vitamin D-binding protein and polymorphism of the vitamin D receptor gene have been reported in patients with migraine, while the relationship between the serum vitamin D level and headache frequency in migraine patients is controversial [2325].

Tension-type headache is the most common primary headache disorder, accounting for most non-migraine headache in population studies. In the Norwegian population, non-migraine type headache was associated with low vitamin D levels with an odds ratio of 1.20 in the lowest quartile compared with the highest quartile group, whereas no significant association was found between migraine and the vitamin D levels [17]. There are also reports that chronic tension-type headache was associated with vitamin D deficiency [2628].

Cluster headache shows a seasonal predilection, with nocturnal attacks [2931]. The diurnal and seasonal variation might be related to sunlight and vitamin D metabolism, suggesting a role for vitamin D in cluster headache. There are no published studies of vitamin D in cluster headache, although a poster presentation showed that an anti-inflammatory regimen of vitamin and mineral supplements including vitamin D3 was effective in preventing cluster headaches [32]. Therefore, we investigated the serum vitamin D level in patients with cluster headache and the relationship between vitamin D deficiency and headache parameters compared with migraineurs and healthy controls.

Methods

Subjects

We enrolled patients with cluster headache and age- and sex-matched migraine patients as headache controls and normal controls in a case–control design. This study collected data from patients with cluster headache and migraine treated in the headache clinics of Chuncheon, Dongtan, and Kangnam Sacred Heart Hospitals of Hallym University College of Medicine from October 2016 to March 2018. All participants were between 20 and 65 years of age, and they were examined and classified according to the beta version of the International Classification of Headache Disorders-3 (ICHD-3β) [33] by a board-certified neurologist based on the patient history, a neurological examination, and neuroimaging studies. The control group consisted of volunteers matched for age, gender, and season enrolled. We recruited the control group via advertisements such as posted notices in the hospital. Control participants were required to be headache free (less than 1 headache day per month for an average of 1 year) with no history of primary or secondary headache disorder by the ICHD-3β [31, 33]. Exclusion criteria included subjects who took a vitamin D supplement or medication that influences vitamin D metabolism (e.g., antiepileptic drugs, rifampin, antiretroviral drugs, etc.), severe obesity [body mass index (BMI) > 30], thyroid or parathyroid disease, diabetes, and severe liver or renal disease.

The study protocol and informed consent form were reviewed and approved by the Institutional Review Board of each hospital (2016-439-I). Written informed consent was obtained from all participants before enrolling them in the study.

Demographic data and questionnaire

Demographic data were obtained from all groups, including age, sex, height, weight, place of residence, occupation, level of education, and smoking habit. The data collected on headache patients included frequency of attacks (per month), average headache duration (hours), severity of pain [assessed with a visual analogue scale (VAS) range 0–10], and days per month using abortive medication. The patients with cluster headache completed a detailed semi-structured questionnaire on the headache characteristics, such as autonomic symptoms, diurnal periodicity, time of propensity, and seasonal periodicity. We contacted the patients after at least 3 months and collected data on the recurrence of headache. Eligible patients were interviewed at follow-up outpatient appointments or by telephone. The headache group completed the Headache Impact Test-6 (HIT-6) to measure headache-related impact, Patient Health Questionnare-9 (PHQ-9) to assess depression, Generalized Anxiety Dirorder-7 (GAD-7) to assess anxiety, and Pittsburgh Sleep Quality Index (PSQI) to measure the quality of sleep [3437].

Measurement and analysis of vitamin D

Non-fasting venous blood samples were collected at the baseline examinations. Serum 25(OH)D concentrations were measured with a chemiluminescent immunoassay using the ARCHITECT i4000 SR (Abbott Diagnostics, IL, USA). The intra- and interassay coefficients of variation of the measurements were 1.7–2.8 and 2.7–4.1%, respectively. The assay was standardized against NIST Standard Reference Material 2972 (NIST, Gaithersburg, ME, USA) and certified by the Centers for Disease Control and Prevention Vitamin D Standardization Program [38]. Vitamin D deficiency was defined as a 25(OH)D < 20 ng/mL, insufficiency as 21–29 ng/mL, and ideal range as 30–50 ng/mL.

The time of the day, month, and year when the vitamin D assessment was performed was recorded [39, 40]. Most experts define vitamin D deficiency as serum 25(OH)D vitamin D levels < 20 ng/mL, although there is no consensus on the optimal serum vitamin D levels [4144]. A cutoff value of 20 ng/mL was used to divide the samples into “deficient” and “normal” groups in this study [14].

Statistics

Analysis of variance (ANOVA) was used to compare demographic and headache parameters among groups, after confirming the normality of the distribution using the Shapiro-Wilk test. If the normality of the distribution was not confirmed, the Kruskal-Wallis, chi-square test or Fisher’s exact test were used to compare data between groups, where appropriate. Serum vitamin D concentrations in subjects with CH, migraine, and controls were compared using analysis of covariance (ANCOVA), with adjustment for potential confounders. The correlations between the serum 25(OH)D concentration and various clinical features were assessed using Pearson’s or Spearman correlation coefficient based on the normality of the distribution.

To compare vitamin D concentration according to the headache parameters among the CH group, the Mann-Whitney test was used. ANOVA was used to compare vitamin D concentrations between subgroups in CH patients. Using linear regression analysis, we calculated the odds ratios of vitamin D levels associated with the headache variables. The variables that showed statistical correlations with the vitamin D levels in the univariate analyses, and factors that are known to affect the vitamin D level, were included in the multivariate regression analysis. Linear regression was used to assess the seasonal propensity of serum 25(OH)D concentrations with factors known to affect vitamin D levels (age, male, current smoker, sampling time) [45]. A p-value < 0.05 was considered statistically significant. All analyses were performed using R version 3.5.0 for Windows (R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/) and RStudio version 1.1.442.

Results

Comparison of demographics and vitamin D levels in patients with cluster headache, migraine, and controls

The study enrolled 28 patients with cluster headache, 36 migraineurs, and 36 normal controls. No significant differences were found in the CH and migraine patients compared with the controls in terms of age (38.2, 35.1, and 35.4 years, respectively) or sex (proportion male 85.7, 80.6, and 88.9%, respectively). In addition, there were no differences in BMI, smoking status, sampling season, and sampling time zones (7-10 AM, 11 AM-1 PM, 2-5 PM) among the three groups (Table 1).
Table 1

Demographic features and vitamin D parameters of the patients with cluster headache, migraineurs, and normal controls

 

Cluster Headache (n = 28)

Migraine (n = 36)

Normal controls (n = 36)

p-value

Age, years

38.2 ± 8.5

35.1 ± 8.2

35.4 ± 9.1

0.189

Men (%)

24 (85.7)

29 (80.6)

32 (88.9)

0.607

BMI, kg/m2

23.3 ± 2.8

23,6 ± 3.7

24.1 ± 3.2

0.583

Smoking habit (%)a

   

0.133

 Current

17 (63.0)

15 (41.7)

14 (38.9)

 

 ex-smoker

3 (11.1)

2 (5.6)

8 (22.2)

 

 Never

7 (25.9)

19 (52.8)

14 (38.9)

 

Pain intensity, VAS

8.5 ± 1.8

6.4 ± 1.7

NA

< 0.001

Vitamin D deficiency (%)

26 (92.8)

29 (80.6)

30 (83.3)

0.771

Distribution of 25(OH)D concentration

   

0.236

 ≥ 30 (ng/mL)

0

1 (2.8)

2 (5.6)

 

 20–29.9 (ng/mL)

2 (7.2)

6 (16.7)

4 (11.1)

 

 10–19.9 (ng/mL)

23 (82.1)

21 (58.3)

19 (52.8)

 

 < 10 (ng/mL)

3 (10.7)

8 (22.2)

11 (30.5)

 

Sampling seasons

   

0.349

 Winter to spring

15 (53.9)

21 (58.3)

15 (41.7)

 

 Summer to autumn

13 (46.4)

15 (41.7)

21 (58.3)

 

Values are expressed as mean ± standard deviation or number (%)

VAS visual analogue scale

adata was not available in one patient with CH

The serum 25(OH)D concentrations were 14.0 ± 3.9 ng/mL in the patients with CH, 14.7 ± 5.9 ng/mL in the migraineurs, and 14.6 ± 7.4 ng/mL in the normal controls (p = 0.884). After adjustment for potential confounders (sex, age, sampling season, current smoking) by ANCOVA, the serum 25(OH)D concentrations were not different between groups (data not shown, p = 0.853). Vitamin D deficiency was present in 92.8% of the patients with CH, 80.6% of the migraineurs, and 83.3% of the normal controls (p = 0.771) There were no significant differences in distribution of serum 25(OH)D concentrations between patients with CH, migraine, and controls (Table 1).

Serum 25(OH)D concentrations were higher in those with a sampling season from summer to autumn than those with a sampling season from winter to spring (15.6 ± 5.2 ng/mL vs. 13.3 ± 6.5 ng/mL, p = 0.003). No differences in serum vitamin D concentrations were evident based on the time of blood sample collection when analyzed at one-hour intervals (data not shown). Furthermore, there were no correlations between serum 25(OH)D concentrations and age, BMI, GAD-7 score, or PHQ-9 score, nor were any differences of the level observed between sexes.

Comparison of vitamin D levels in the patients with cluster headache according to clinical factors

In patients with CH, there was no difference in the serum 25(OH)D concentrations between men and women, cluster and remission periods, first and recurrent attack, presence and absence of daily or seasonal periodicity, and 3-month recurrence (p > 0.05). In the 14 patients with seasonal periodicity, patients with periodicity of winter to spring had a trend toward lower serum 25(OH)D concentrations than those with periodicity of summer to autumn (12.30 ± 1.58 vs. 16.96 ± 4.69 ng/mL, p = 0.097, Table 2).
Table 2

Vitamin D levels according to clinical variables in the patients with cluster headache

 

25(OH)D, ng/mL

p-value

Sex

 

0.646

 Men (n = 24)

13.95 ± 4.08

 

 Women (n = 4)

14.33 ± 2.82

 

Recurrence

 

0.300

 First episode (n = 6)

14.83 ± 2.42

 

 Recurrent episode (n = 22)

13.78 ± 4.21

 

Paired comparison

 

0.421

 Cluster period (n = 14)

13.87 ± 3.64

 

 Remission period (n = 14)

14.06 ± 4.56

 

Diurnal periodicity

 

0.728

 Present (n = 16)

13.69 ± 3.47

 

 Absent (n = 12)

14.41 ± 4.50

 

Time of propensity

 

0.125

 Nighttime propensity (n = 9)

14.72 ± 3.63

 

 Daytime propensity (n = 7)

11.71 ± 2.63

 

Recurrence at 3 months

 

0.562

 present (n = 2)

13.00 ± 3.39

 

 absent (n = 26)

14.08 ± 3.97

 

Seasonal periodicity

 

0.188

 Present (n = 14)

14.63 ± 4.14

 

 Absent (n = 8)

12.29 ± 4.18

 

Season of cluster period

 

0.097

 Winter to spring (n = 7)

12.30 ± 1.58

 

 Summer to autumn (n = 7)

16.96 ± 4.69

 

Sampling season

 

0.001

 Winter to spring (n = 15)

11.91 ± 2.63

 

 Summer to autumn (n = 13)

16.41 ± 3.76

 
Vitamin D levels were significantly lower in the subgroup with sampling season between winter to spring relative to other groups. Therefore, we analyzed vitamin D levels in the CH subgroups according to seasonal propensity, and by sample season for the 22 CH patients with recurrence (Table 3). There were significant differences in vitamin D levels between six groups; however, the differences between sampling seasons were not significant. There was no correlation between the vitamin D level and daily frequency, average weeks of cluster period, total bout of cluster period, or HIT-6, GAD-7, or PHQ-9 score.
Table 3

The 25(OH)D concentration according seasonal propensity and sample seasons in 22 CH patients with recurrence

According to sample seasons

Seasonal propensity

No seasonal propensity (n = 8)

p-value

Winter to spring (n = 7)

Summer to autumn (n = 7)

Winter to spring (n = 12)

12.28 ± 1.93a (n = 5)

13.00 ± 3.39c (n = 2)

9.48 ± 1.61e (n = 5)

0.001

Summer to autumn (n = 10)

12.35 ± 0.07b (n = 2)

18.54 ± 4.38d (n = 5)

16.97 ± 1.82f (n = 3)

 

One-way analysis of variance (ANOVA) was done based on normal distribution of vitamin D level among 28 patients with cluster headache. According to post-hoc analysis between 6 groups using Turkey HSD, p-values between a and d was 0.023, p-value between d and e was < 0.001, and p-value between e and f was 0.018. The other comparisons were not significant

CH cluster headache

Clinical factors associated with vitamin D levels

The univariate linear analysis showed that sampling from summer to autumn and seasonal propensity for summer to autumn showed significant correlations with the vitamin D level. In the multiple linear regression analysis, however, the significance of seasonal propensity for summer to autumn was lost after adjusting for the sampling season. No changes in significance were observed by the multiple linear regression analysis when controlling for age, current smoking status, and sampling time zone (Additional file 1: Table S1).

Discussion

This study suggested that vitamin D deficiency is very common in patients with cluster headache compared with the prevalence of vitamin D deficiency in Korean adults [14]. However, the significance of vitamin D deficiency is uncertain, except for a subtle seasonal influence.

A few recent observational studies suggested that low serum vitamin D levels were related to some headache disorders, especially migraine and tension-type headache [24, 28, 46, 47]. One study also reported significant relations of lifetime prevalence of both migraine and tension-type headache with latitude [16]. If vitamin D has any association with headache, the prevalence of headache should match the seasonal variation in vitamin D levels. There are data indicating an increased frequency of headache attacks in autumn–winter and the least number of attacks in summer, although there are few studies on the seasonal variation of primary headache disorders, such as migraine and tension-type headache [4850].

However, the relationship between cluster headache and vitamin D has not been studied previously, although cluster headache has characteristic seasonal rhythmicity. Cluster headache is a primary headache disorder characterized by a unique seasonal and diurnal periodicity. These characteristic features of its periodicity suggest involvement of the hypothalamus, the biological clock [51]. In Korea, seasonal propensity and diurnal periodicity were present in 44.0 and 68.5% of the patients with cluster headache, respectively. Among patients with seasonal propensity and diurnal periodicity, the most frequently cited season and time was spring (37.5%) and night (66.4%), respectively [52]. An inverse relationship between sunshine duration and the monthly incidence of cluster periods was reported in a hospital-based study [53]. A follow-up population-based study found positive correlations between average temperature and sunshine duration with occurrence of cluster periods, and that temperature was associated with precipitating or priming cluster periods [30]. Based on previous results, it is possible that vitamin D and cluster headaches are related. However, our study did not find significant differences in the vitamin D level among cluster headache, migraine, and controls. Although there was no significant difference among groups, the prevalence of vitamin D deficiency was higher in the cluster headache group than in the migraine and control groups. This suggests that vitamin D deficiency is very common in patients with cluster headache compared with the prevalence of vitamin D deficiency in Korean adults [14]. There was also no significant difference in vitamin D levels according to clinical variables in the patients with cluster headache. However, patients with periodicity of winter to spring had a trend of lower serum 25(OH)D concentrations than those with periodicity of summer to autumn in patients with seasonal periodicity. The serum vitamin D level varies with the season, peaking in May to September. The levels tend to be lower from November to March [5456]. Therefore, we used an arbitrary classification of the sunny season, i.e., summer to autumn, winter to spring.

The vitamin D receptor and 1α-hydroxylase, the enzyme responsible for the formation of the active vitamin, are present in many parts of the central nervous system, including the prefrontal cortex, hippocampus, cingulate gyrus, thalamus, and hypothalamus. The strongest immunohistochemical staining for both the receptor and enzyme was in the hypothalamus [57]. Vitamin D-binding protein was also detected in axonal projections throughout the lateral hypothalamus in the rat [58]. The presence of the vitamin D receptor, 1α-hydroxylase, and vitamin D-binding protein in the hypothalamus suggests a role of vitamin D deficiency in the generation of various primary headache disorders. In addition to the hypothalamus, there is evidence that the pineal gland has a role in the biological regulation of circadian rhythms by producing melatonin [59]. Sunshine has been reported to regulate specific hormonal and neurotransmitter levels, including melatonin [60]. Altered melatonin levels have been documented in cluster headache and the nocturnal serum melatonin level was decreased during cluster periods [61]. Based on the characteristic clinical features and proposed mechanisms of cluster headache, we hypothesized that vitamin D and cluster headache are related. However, our study failed to find any correlations between the serum vitamin D levels and headache characteristics, such as the seasonal and circadian rhythmicity of cluster headache or the association between serum vitamin D levels and recurrence of cluster headache. To determine the associations between vitamin D and the recurrence in cluster headache, a further longitudinal follow-up study of a larger population is required.

Various factors influence serum vitamin D levels, making, it is difficult to speculate on the role of vitamin D in the pathophysiology of cluster headache. Our study could not control for all of the environmental and demographic factors that significantly affect the serum vitamin D levels There was no information on the exposure of the subjects to sunlight, their sun protection habits or the extent of vitamin D supplementation through food, though we did collect information on smoking status, BMI, sampling time, and sampling season, all of which are known to influence vitamin D concentration. We also analyzed the influence of these variables on serum vitamin D levels. There were no significant differences in smoking status and BMI among the three groups. Additionally, current smoking was not a significant determinant of serum vitamin D levels in this study population using multivariate regression analysis. Second, our study had a relatively small sample size due to the rarity of cluster headache. This study suggests that the influence of vitamin D may warrant analysis in a larger cohort of CH patients with seasonal propensity for winter to spring. This study also included mostly men, due to a sex-matched research design, so these findings may not be truly representative of migraine and normal controls, or generalizable to other groups. Third, the outcome variables collected, such as the seasonal propensity, were assessed on self-report by recall and the classification of the sunny season was arbitrary. While we did not obtain fasting serum samples, there were no significant differences in sampling times among the three groups based on the time the blood samples were collected.

Conclusions

In summary, this is the first report to examine serum vitamin D levels in patients with CH compared to those of age-and sex-matched controls controlling for sampling season as well as other clinical variables.. Our preliminary findings suggest that vitamin D deficiency is very common in patients with cluster headache, but the significance of vitamin D deficiency is uncertain, except for the subtle seasonal influence. Further research is needed to determine the role of vitamin D in CH.

Abbreviations

BMI: 

Body mass index

GAD-7: 

Generalized Anxiety Dirorder-7

HIT-6: 

Headache Impact Test-6

ICHD-3β: 

Beta version of the International Classification of Headache Disorders-3

PHQ-9: 

Patient Health Questionnare-9

PSQI: 

Pittsburgh Sleep Quality Index

SE: 

Standard error

VAS: 

Visual analogue scale

Declarations

Acknowledgements

Thanks to my research coordinator, Jung Eun Kwon for sincere cooperation during the procedure.

Funding

This study was supported by Hallym University Research Fund (HURF-2016-54). The role of funding was in the design of the study and collection, analysis, and interpretation of data. No other financial relationships relevant to this publication were disclosed.

Availability of data and materials

Available as supplementary data.

Authors’ contributions

Conception and design of the experiments: SJC, KYP, JHS, MKC, HYA; Performance of data collection: SJC, JHS, MKC; Data analysis: SJC, KYP, HYA. Writing of the manuscript and final approval: SJC, KYP, JHS, MKC, HYA.

Ethics approval and consent to participate

The study protocol and informed consent form were reviewed and approved by the Institutional Review Board of each hospital (Dongtan Sacred Heart Hospital approval no. 2016-439-I; Chuncheon Sacred Heart Hospital approval no. 2016-131; Kangnam Sacred Heart Hospital approval no. 2016-11-157). Written informed consent was obtained from all participants before enrolling them in the study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon-si, Gangwon-do, Korea
(2)
Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
(3)
Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea
(4)
Department of Statistics, Dongguk University-Seoul, Seoul, Korea
(5)
Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Keun Jae Bong-gil 7, Hwaseong, Gyeonggi-do, 18450, Korea

References

  1. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Grantham N, Ebeling PR, Daly RM (2011) Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care 34(5):1133–1138. https://doi.org/10.2337/dc10-2167 View ArticlePubMedPubMed CentralGoogle Scholar
  2. Ju SY, Lee YJ, Jeong SN (2013) Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. J Nutr Health Aging 17(5):447–455. https://doi.org/10.1007/s12603-012-0418-0 View ArticlePubMedGoogle Scholar
  3. Afzal S, Bojesen SE, Nordestgaard BG (2014) Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement 10(3):296–302. https://doi.org/10.1016/j.jalz.2013.05.%2017%2065 View ArticlePubMedGoogle Scholar
  4. Autier P, Boniol M, Pizot C, Mullie P (2014) Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2(1):76–89. https://doi.org/10.1016/s2213-8587(13)70165-7 View ArticlePubMedGoogle Scholar
  5. Chen WR, Qian YA, Chen YD, Shi Y, Yin d W, Wang H, Zhu P, Liu HW, Sha Y (2014) The effects of low vitamin D on coronary artery disease. Heart Lung Circ 23(4):314–319. https://doi.org/10.1016/j.hlc.2013.08.012 View ArticlePubMedGoogle Scholar
  6. Annweiler C, Dursun E, Feron F, Gezen-Ak D, Kalueff AV, Littlejohns T, Llewellyn DJ, Millet P, Scott T, Tucker KL, Yilmazer S, Beauchet O (2015) ‘Vitamin D and cognition in older adults’: updated international recommendations. J Intern Med 277(1):45–57. https://doi.org/10.1111/joim.12279 View ArticlePubMedGoogle Scholar
  7. Gill TK, Hill CL, Shanahan EM, Taylor AW, Appleton SL, Grant JF, Shi Z, Dal Grande E, Price K, Adams RJ (2014) Vitamin D levels in an Australian population. BMC Public Health 14:1001. https://doi.org/10.1186/1471-2458-14-1001 View ArticlePubMedPubMed CentralGoogle Scholar
  8. Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169(6):626–632. https://doi.org/10.1001/archinternmed.2008.604 View ArticlePubMedPubMed CentralGoogle Scholar
  9. Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, Sarafin K, Poliquin S, Krieger J, Richards JB, Goltzman D (2011) 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 22(5):1389–1399. https://doi.org/10.1007/s00198-010-1362-7 View ArticlePubMedGoogle Scholar
  10. Hypponen E, Power C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85(3):860–868. https://doi.org/10.1093/ajcn/85.3.860 View ArticlePubMedGoogle Scholar
  11. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30(5):771–777View ArticlePubMedGoogle Scholar
  12. Rockell JE, Skeaff CM, Williams SM, Green TJ (2006) Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int 17(9):1382–1389. https://doi.org/10.1007/s00198-006-0118-x View ArticlePubMedGoogle Scholar
  13. Thuesen B, Husemoen L, Fenger M, Jakobsen J, Schwarz P, Toft U, Ovesen L, Jorgensen T, Linneberg A (2012) Determinants of vitamin D status in a general population of Danish adults. Bone 50(3):605–610. https://doi.org/10.1016/j.bone.2011.12.016 View ArticlePubMedGoogle Scholar
  14. Jeong H, Hong S, Heo Y, Chun H, Kim D, Park J, Kang MY (2014) Vitamin D status and associated occupational factors in Korean wage workers: data from the 5th Korea national health and nutrition examination survey (KNHANES 2010-2012). Ann Occup Environ Med 26:28. https://doi.org/10.1186/s40557-014-0028-x View ArticlePubMedPubMed CentralGoogle Scholar
  15. Kimlin MG, Lucas RM, Harrison SL, van der Mei I, Armstrong BK, Whiteman DC, Kricker A, Nowak M, Brodie AM, Sun J (2014) The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD study. Am J Epidemiol 179(7):864–874. https://doi.org/10.1093/aje/kwt446 View ArticlePubMedGoogle Scholar
  16. Prakash S, Mehta NC, Dabhi AS, Lakhani O, Khilari M, Shah ND (2010) The prevalence of headache may be related with the latitude: a possible role of vitamin D insufficiency? J Headache Pain 11(4):301–307. https://doi.org/10.1007/s10194-010-0223-2 View ArticlePubMedPubMed CentralGoogle Scholar
  17. Kjaergaard M, Eggen AE, Mathiesen EB, Jorde R (2012) Association between headache and serum 25-hydroxyvitamin D: the Tromso study: Tromso 6. Headache 52(10):1499–1505. https://doi.org/10.1111/j.1526-4610.2012.02250.x View ArticlePubMedGoogle Scholar
  18. Lippi G, Cervellin G, Mattiuzzi C (2014) No evidence for an association of vitamin D deficiency and migraine: a systematic review of the literature. Biomed Res Int 2014:827635. https://doi.org/10.1155/2014/827635 View ArticlePubMedPubMed CentralGoogle Scholar
  19. Zandifar A, Masjedi SS, Banihashemi M, Asgari F, Manouchehri N, Ebrahimi H, Haghdoost F, Saadatnia M (2014) Vitamin D status in migraine patients: a case-control study. Biomed Res Int 2014:514782. https://doi.org/10.1155/2014/514782 PubMedPubMed CentralView ArticleGoogle Scholar
  20. Thys-Jacobs S (1994) Vitamin D and calcium in menstrual migraine. Headache 34(9):544–546View ArticlePubMedGoogle Scholar
  21. Mottaghi T, Askari G, Khorvash F, Maracy MR (2015) Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci 20(5):477–482View ArticlePubMedPubMed CentralGoogle Scholar
  22. Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, Burstein R (2015) Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial. Ann Neurol 78(6):970–981. https://doi.org/10.1002/ana.24534 View ArticlePubMedPubMed CentralGoogle Scholar
  23. Motaghi M, Haghjooy Javanmard S, Haghdoost F, Tajadini M, Saadatnia M, Rafiee L, Zandifar A (2013) Relationship between vitamin D receptor gene polymorphisms and migraine without aura in an Iranian population. Biomed Res Int 2013:351942. https://doi.org/10.1155/2013/351942 View ArticlePubMedPubMed CentralGoogle Scholar
  24. Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, Iraj B (2013) The relationship between serum levels of vitamin D and migraine. J Res Med Sci 18(Suppl 1):S66–S70PubMedPubMed CentralGoogle Scholar
  25. Nagata E, Fujii N, Hosomichi K, Mitsunaga S, Suzuki Y, Mashimo Y, Tsukamoto H, Satoh T, Osawa M, Inoue I, Hata A, Takizawa S (2014) Possible association between dysfunction of vitamin D binding protein (GC globulin) and migraine attacks. PLoS One 9(8):e105319. https://doi.org/10.1371/journal.pone.0105319 View ArticlePubMedPubMed CentralGoogle Scholar
  26. Prakash S, Makwana P, Rathore C (2016) Vitamin D deficiency mimicking chronic tension-type headache in children. BMJ Case Rep 2. https://doi.org/10.1136/bcr-2015-213833
  27. Prakash S, Rathore C, Makwana P, Dave A, Joshi H, Parekh H (2017) Vitamin D deficiency in patients with chronic tension-type headache: a case-control study. Headache 57(7):1096–1108. https://doi.org/10.1111/head.13096 View ArticlePubMedGoogle Scholar
  28. Prakash S, Shah ND (2009) Chronic tension-type headache with vitamin D deficiency: casual or causal association? Headache 49(8):1214–1222. https://doi.org/10.1111/j.1526-4610.2009.01483.x View ArticlePubMedGoogle Scholar
  29. Rozen TD, Fishman RS (2012) Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 52(1):99–113. https://doi.org/10.1111/j.1526-4610.2011.02028.x View ArticlePubMedGoogle Scholar
  30. Lee YJ, Chen YT, Ou SM, Li SY, Yang AC, Tang CH, Wang SJ (2014) Temperature variation and the incidence of cluster headache periods: a nationwide population study. Cephalalgia 34(9):656–663. https://doi.org/10.1177/0333102413520083 View ArticlePubMedGoogle Scholar
  31. Barloese MC (2015) Neurobiology and sleep disorders in cluster headache. J Headache Pain 16:562. https://doi.org/10.1186/s10194-015-0562-0 View ArticlePubMedGoogle Scholar
  32. Peter B (2014) A survey of cluster headache (CH) sufferers using vitamin D3 as a CH preventative. Poster presented of the 66th Annual meeting of American Acedemy of Neurology, Philadelphia, April 26–May 03, 2014Google Scholar
  33. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808. https://doi.org/10.1177/0333102413485658 View ArticleGoogle Scholar
  34. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213View ArticlePubMedGoogle Scholar
  35. Chu MKIH, Ju YS, Yu KH, Ma HI, Kim YJ et al (2009) Validity and reliability assessment of Korean headache impact test-6 (HIT-6). J Korean Neurol Assoc 2009(27):1–6Google Scholar
  36. Seo JG, Park SP (2015) Validation of the patient health questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 16:65. https://doi.org/10.1186/s10194-015-0552-2 View ArticlePubMedPubMed CentralGoogle Scholar
  37. Seo J-G, Park S-P (2015) Validation of the generalized anxiety disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 16(1):97View ArticlePubMedPubMed CentralGoogle Scholar
  38. CDC Vitamin D Standardization-Certification Program (VDSCP)—Total 25hydroxy Vitamin D Certified Procedures (2017) https://www.cdc.gov/labstandards/pdf/hs/CDC_Certified_Vitamin_D_Procedures.pdf. Accessed 8 Dec 2017
  39. Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165. https://doi.org/10.1007/s11154-017-9424-1 View ArticlePubMedGoogle Scholar
  40. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385 View ArticlePubMedGoogle Scholar
  41. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338(12):777–783. https://doi.org/10.1056/nejm199803193381201 View ArticlePubMedGoogle Scholar
  42. Malabanan A, Veronikis IE, Holick MF (1998) Redefining vitamin D insufficiency. Lancet 351(9105):805–806View ArticlePubMedGoogle Scholar
  43. Hollis BW, Wagner CL (2005) Normal serum vitamin D levels. N Engl J Med 352(5):515–516; author reply 515-516. https://doi.org/10.1056/nejm200502033520521 PubMedView ArticleGoogle Scholar
  44. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353–373. https://doi.org/10.4065/81.3.353 View ArticlePubMedGoogle Scholar
  45. Masood T, Kushwaha RS, Singh R, Sailwal S, Pandey H, Varma A, Singh RK, Cornelissen G (2015) Circadian rhythm of serum 25 OH vitamin D, calcium and phosphorus levels in the treatment and management of type-2 diabetic patients. Drug Discov Therap 9(1):70–74. https://doi.org/10.5582/ddt.2015.01002 View ArticleGoogle Scholar
  46. Prakash S, Kumar M, Belani P, Susvirkar A, Ahuja S (2013) Interrelationships between chronic tension-type headache, musculoskeletal pain, and vitamin D deficiency: is osteomalacia responsible for both headache and musculoskeletal pain? Ann Indian Acad Neurol 16(4):650–658. https://doi.org/10.4103/0972-2327.120487 View ArticlePubMedPubMed CentralGoogle Scholar
  47. Celikbilek A, Gocmen AY, Zararsiz G, Tanik N, Ak H, Borekci E, Delibas N (2014) Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from Central Anatolia region. Int J Clin Pract 68(10):1272–1277. https://doi.org/10.1111/ijcp.12456 View ArticlePubMedGoogle Scholar
  48. Soriani S, Fiumana E, Manfredini R, Boari B, Battistella PA, Canetta E, Pedretti S, Borgna-Pignatti C (2006) Circadian and seasonal variation of migraine attacks in children. Headache 46(10):1571–1574. https://doi.org/10.1111/j.1526-4610.2006.00613.x View ArticlePubMedGoogle Scholar
  49. Marrelli A, Marini C, Prencipe M (1988) Seasonal and meteorological factors in primary headaches. Headache 28(2):111–113View ArticlePubMedGoogle Scholar
  50. Cugini P, Romit A, Di Palma L, Giacovazzo M (1990) Common migraine as a weekly and seasonal headache. Chronobiol Int 7(5–6):467–469View ArticlePubMedGoogle Scholar
  51. Pringsheim T (2002) Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci 29(1):33–40View ArticlePubMedGoogle Scholar
  52. Heui-Soo Moon JWP, Kwang-Soo Lee C-SC, Byung-Kun Kim J-MK, Jong-Hee Sohn MKC, Oh K, Cho SJ (2017) Clinical features of cluster headache patients in Korea. J Korean Med Sci 32(3):502–506. https://doi.org/10.3346/jkms.2017.32.3.502 View ArticlePubMedPubMed CentralGoogle Scholar
  53. Lin KH, Wang PJ, Fuh JL, Lu SR, Chung CT, Tsou HK, Wang SJ (2004) Cluster headache in the Taiwanese - a clinic-based study. Cephalalgia 24(8):631–638. https://doi.org/10.1111/j.1468-2982.2003.00721.x View ArticlePubMedGoogle Scholar
  54. Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V (2002) Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 87(5):2024–2032. https://doi.org/10.1210/jcem.87.5.8475 View ArticlePubMedGoogle Scholar
  55. Prince PB, Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (2004) The effect of weather on headache. Headache 44(6):596–602. https://doi.org/10.1111/j.1526-4610.2004.446008.x View ArticlePubMedGoogle Scholar
  56. Maxwell JD (1994) Seasonal variation in vitamin D. Proc Nutr Soc 53(3):533–543View ArticlePubMedGoogle Scholar
  57. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29(1):21–30. https://doi.org/10.1016/j.jchemneu.2004.08.006 View ArticlePubMedGoogle Scholar
  58. Jirikowski GF, Kaunzner UW, Dief Ael E, Caldwell JD (2009) Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus. Histochem Cell Biol 131(3):365–370. https://doi.org/10.1007/s00418-008-0540-6 View ArticlePubMedGoogle Scholar
  59. Peres MF (2005) Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 25(6):403–411. https://doi.org/10.1111/j.1468-2982.2005.00889.x View ArticlePubMedGoogle Scholar
  60. Golombek DA, Rosenstein RE (2010) Physiology of circadian entrainment. Physiol Rev 90(3):1063–1102. https://doi.org/10.1152/physrev.00009.2009 View ArticlePubMedGoogle Scholar
  61. Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L (1987) Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 50(2):207–213View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement